Literature DB >> 9192627

Monomeric isomers of human interleukin 5 show that 1:1 receptor recruitment is sufficient for function.

J Li1, R Cook, M L Doyle, P Hensley, D E McNulty, I Chaiken.   

Abstract

The normally dimeric human interleukin 5 (IL-5) was re-engineered into two monomeric isomer forms to investigate mechanistic features of receptor recognition. One form, denoted GM1-IL-5, is a CD-loop expanded form, in which an 8-residue linker designed for flexibility was inserted between residues 85 and 86. The second, denoted DABC-IL-5, is a circularly permuted form of human IL-5 in which a chain discontinuity was introduced in the CD loop and the two consequent chain fragments were joined at the normal N and C termini by a di-glycyl linker. Both IL-5 isomers folded into stable monomers in solution as shown by sedimentation equilibrium and CD and formed an intrachain disulfide bond predicted from the structure of wild type IL-5. From titration microcalorimetry and optical biosensor analyses, both monomers were shown to interact with the IL-5 receptor alpha chain with 1:1 stoichiometry and affinities 30- to 40-fold weaker than for the dimeric wild type protein. And both monomers stimulated cell proliferation of human IL-5 receptor positive cells with a concentration dependence close to that of wild type. The data show that both monomeric and dimeric forms of IL-5 function through similar 1:1 receptor alpha chain recruitment processes and that it is the helical packing of the monomeric four-helix bundle unit in IL-5, rather than the helical connectivity itself, that appears to play the major role in presenting structural epitopes to trigger functional receptor activation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192627      PMCID: PMC21220          DOI: 10.1073/pnas.94.13.6694

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

Review 1.  GM-CSF, IL-3 and IL-5: cross-competition on human haemopoietic cells.

Authors:  A F Lopez; M J Elliott; J Woodcock; M A Vadas
Journal:  Immunol Today       Date:  1992-12

Review 2.  Pharmacological implications of interleukin-5 in the control of eosinophilia.

Authors:  C J Sanderson
Journal:  Adv Pharmacol       Date:  1992

Review 3.  Circularly permuted proteins.

Authors:  D P Goldenberg
Journal:  Protein Eng       Date:  1989-05

4.  A fully active variant of dihydrofolate reductase with a circularly permuted sequence.

Authors:  A Buchwalder; H Szadkowski; K Kirschner
Journal:  Biochemistry       Date:  1992-02-18       Impact factor: 3.162

Review 5.  Circularly permuted DNA, RNA and proteins--a review.

Authors:  T Pan; O C Uhlenbeck
Journal:  Gene       Date:  1993-03-30       Impact factor: 3.688

6.  Mutational effects on inclusion body formation in the periplasmic expression of the immunoglobulin VL domain REI.

Authors:  W Chan; L R Helms; I Brooks; G Lee; S Ngola; D McNulty; B Maleeff; P Hensley; R Wetzel
Journal:  Fold Des       Date:  1996

Review 7.  T lymphocytes and their products in atopic allergy and asthma.

Authors:  A B Kay
Journal:  Int Arch Allergy Appl Immunol       Date:  1991

8.  Recombinant soluble human interleukin-5 (hIL-5) receptor molecules. Cross-linking and stoichiometry of binding to IL-5.

Authors:  R Devos; Y Guisez; S Cornelis; A Verhee; J Van der Heyden; M Manneberg; H W Lahm; W Fiers; J Tavernier; G Plaetinck
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

9.  Novel fold and putative receptor binding site of granulocyte-macrophage colony-stimulating factor.

Authors:  K Diederichs; T Boone; P A Karplus
Journal:  Science       Date:  1991-12-20       Impact factor: 47.728

10.  A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF.

Authors:  J Tavernier; R Devos; S Cornelis; T Tuypens; J Van der Heyden; W Fiers; G Plaetinck
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

View more
  2 in total

1.  Asymmetric usage of antagonist charged residues drives interleukin-5 receptor recruitment but is insufficient for receptor activation.

Authors:  Tetsuya Ishino; Udaya Pillalamarri; Dominick Panarello; Madhushree Bhattacharya; Cecilia Urbina; Stephanie Horvat; Sanjay Sarkhel; Bradford Jameson; Irwin Chaiken
Journal:  Biochemistry       Date:  2006-01-31       Impact factor: 3.162

2.  3D domain swapping causes extensive multimerisation of human interleukin-10 when expressed in planta.

Authors:  Lotte B Westerhof; Ruud H P Wilbers; Jan Roosien; Jan van de Velde; Aska Goverse; Jaap Bakker; Arjen Schots
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.